These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31626957)

  • 1. Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey.
    Balci S; Ekinci RMK; de Jesus AA; Goldbach-Mansky R; Yilmaz M
    Clin Immunol; 2020 Mar; 212():108273. PubMed ID: 31626957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.
    Clarke SLN; Robertson L; Rice GI; Seabra L; Hilliard TN; Crow YJ; Ramanan AV
    Pediatr Rheumatol Online J; 2020 May; 18(1):37. PubMed ID: 32398023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome.
    Volpi S; Insalaco A; Caorsi R; Santori E; Messia V; Sacco O; Terheggen-Lagro S; Cardinale F; Scarselli A; Pastorino C; Moneta G; Cangemi G; Passarelli C; Ricci M; Girosi D; Derchi M; Bocca P; Diociaiuti A; El Hachem M; Cancrini C; Tomà P; Granata C; Ravelli A; Candotti F; Picco P; DeBenedetti F; Gattorno M
    J Clin Immunol; 2019 Jul; 39(5):476-485. PubMed ID: 31144250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy.
    Wu J; Zhou Q; Zhou H; Lu M
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):131. PubMed ID: 37884945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).
    Kanazawa N; Ishii T; Takita Y; Nishikawa A; Nishikomori R
    Pediatr Rheumatol Online J; 2023 Apr; 21(1):38. PubMed ID: 37087470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient with stimulator of interferon genes-associated vasculopathy with onset in infancy without skin vasculopathy.
    Raffaele CGL; Messia V; Moneta G; Caiello I; Federici S; Pardeo M; Bracaglia C; De Benedetti F; Insalaco A
    Rheumatology (Oxford); 2020 Apr; 59(4):905-907. PubMed ID: 31598716
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China].
    Yu ZX; Zhong LQ; Song HM; Wang CY; Wang W; Li J; Ma MS
    Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):179-185. PubMed ID: 29518827
    [No Abstract]   [Full Text] [Related]  

  • 8. STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib.
    Tang X; Xu H; Zhou C; Peng Y; Liu H; Liu J; Li H; Yang H; Zhao S
    J Clin Immunol; 2020 Jan; 40(1):114-122. PubMed ID: 31705453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome.
    Berrada KR; Belot A; Neven B; Ohlmann C; Tronc F; Rice G; Thouvenin G; Dubus JC; Mazenq J; Frémond ML; Stremler N; Soummer-Feuillet S; Cottin V; Reix P
    J Clin Immunol; 2023 Nov; 43(8):2156-2164. PubMed ID: 37814086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.
    Frémond ML; Hadchouel A; Berteloot L; Melki I; Bresson V; Barnabei L; Jeremiah N; Belot A; Bondet V; Brocq O; Chan D; Dagher R; Dubus JC; Duffy D; Feuillet-Soummer S; Fusaro M; Gattorno M; Insalaco A; Jeziorski E; Kitabayashi N; Lopez-Corbeto M; Mazingue F; Morren MA; Rice GI; Rivière JG; Seabra L; Sirvente J; Soler-Palacin P; Stremler-Le Bel N; Thouvenin G; Thumerelle C; Van Aerde E; Volpi S; Willcocks S; Wouters C; Breton S; Molina T; Bader-Meunier B; Moshous D; Fischer A; Blanche S; Rieux-Laucat F; Crow YJ; Neven B
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):803-818.e11. PubMed ID: 33217613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
    Sanchez GAM; Reinhardt A; Ramsey S; Wittkowski H; Hashkes PJ; Berkun Y; Schalm S; Murias S; Dare JA; Brown D; Stone DL; Gao L; Klausmeier T; Foell D; de Jesus AA; Chapelle DC; Kim H; Dill S; Colbert RA; Failla L; Kost B; O'Brien M; Reynolds JC; Folio LR; Calvo KR; Paul SM; Weir N; Brofferio A; Soldatos A; Biancotto A; Cowen EW; Digiovanna JJ; Gadina M; Lipton AJ; Hadigan C; Holland SM; Fontana J; Alawad AS; Brown RJ; Rother KI; Heller T; Brooks KM; Kumar P; Brooks SR; Waldman M; Singh HK; Nickeleit V; Silk M; Prakash A; Janes JM; Ozen S; Wakim PG; Brogan PA; Macias WL; Goldbach-Mansky R
    J Clin Invest; 2018 Jul; 128(7):3041-3052. PubMed ID: 29649002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Tofacitinib for infant-onset STING-associated vasculopathy: A case report from China.
    Shen D; Fan X; Zhou Q; Xu X; Lu M
    Medicine (Baltimore); 2022 Dec; 101(48):e31832. PubMed ID: 36482559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING-associated vasculopathy with onset in infancy: a familial case series report and literature review.
    Wang Y; Wang F; Zhang X
    Ann Transl Med; 2021 Jan; 9(2):176. PubMed ID: 33569478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.
    Latour-Álvarez I; Murcia-Clemente L; Vázquez Pigueiras I; Garramone-Ramírez JE; Clemente D; Sanz V; Torrelo A
    Pediatr Dermatol; 2024; 41(5):893-896. PubMed ID: 38682895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of STING-associated vasculopathy with onset in infancy with novel STING1 variant.
    Barry KK; Kranseler JS; Robinson SN
    Pediatr Dermatol; 2024; 41(4):697-700. PubMed ID: 38369300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Acute Thrombotic Microangiopathy in a Patient with STING-Associated Vasculopathy with Onset in Infancy (SAVI).
    Ma M; Mazumder S; Kwak H; Adams M; Gregory M
    J Clin Immunol; 2020 Nov; 40(8):1111-1115. PubMed ID: 32860170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.
    Gao KM; Motwani M; Tedder T; Marshak-Rothstein A; Fitzgerald KA
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2202327119. PubMed ID: 35696583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel STING variant triggers endothelial toxicity and SAVI disease.
    Valeri E; Breggion S; Barzaghi F; Abou Alezz M; Crivicich G; Pagani I; Forneris F; Sartirana C; Costantini M; Costi S; Marino A; Chiarotto E; Colavito D; Cimaz R; Merelli I; Vicenzi E; Aiuti A; Kajaste-Rudnitski A
    J Exp Med; 2024 Sep; 221(9):. PubMed ID: 38953896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Challenge of Diagnosing SAVI: Case Studies.
    Cao Y; Jiang LP
    Pediatr Allergy Immunol Pulmonol; 2019 Dec; 32(4):167-172. PubMed ID: 32140288
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.
    Wan R; Fänder J; Zakaraia I; Lee-Kirsch MA; Wolf C; Lucas N; Olfe LI; Hendrich C; Jonigk D; Holzinger D; Steindor M; Schmidt G; Davenport C; Klemann C; Schwerk N; Griese M; Schlegelberger B; Stehling F; Happle C; Auber B; Steinemann D; Wetzke M; von Hardenberg S
    Front Immunol; 2022; 13():1029423. PubMed ID: 36275728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.